November 5, 2021
Harnessing the power of biomarkers from discovery to late-stage clinical development and companion diagnostics (CDx)
You might also be interested by
Videos
Poster Video: Induction of an effective immune response is an essential element of cancer immunotherapy
September 2, 2025
Histopathology
More infoPosters
Development of a Pathologist Scoring Method to Determine Inflamed, Excluded or Desert Immune Phenotype in Carcinoma
March 5, 2025
Histopathology
More infoScientific Publications
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer
January 27, 2025
Histopathology
More info